Effect of Gastrectomy on Gut Microbiome and Cognitive Function

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-80
SponsorJiangjiang Bi

About this trial

Perioperative neurocognitive disorders is a common postoperative complication in elderly surgical patients. The role of gut microbiota in cognitive function has been concerned in recent years. Studies suggests that gastrointestinal surgery may affect the gut microbiota, and the effect varies between surgical procedures. In this study, the investigators will compare the differences of gut microbiota between total gastrectomy and double-tract reconstruction, to investigate the effect of gastric acid on the gut microbiota colonizing, and the effect of different surgical procedures on the postoperative cognitive function of proximal gastric cancer patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Clinical diagnosis of proximal gastric cancer and will be performed gastrectomy

American Society of Anesthesiologists (ASA) classification I-III

Aged 40-80 years

Perioperative consciousness

Disqualifiers

Central nervous system and psychological disorders

Chronic use of sedatives, antidepressants within the last year

Parkinson's disease

Severe immunosuppression

Trial population

Patients undergoing proximal gastric cancer surgery with general anesthesia

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • probiotics

    Dietary supplement

    patients undergoing total gastrectomy take probiotics qd for 3 months

Treatment groups

45 Participants
are divided into 3 treatment groups
Group A: Probiotics (PR)1 intervention
Group B: Total gastrectomy (TG)0 interventions
Group C: Double-tract reconstruction (DTR)0 interventions

Trial outcomes

Primary outcomes

1

Cognitive function

The participants will be evaluated by Mini-mental State Examination scales, and diagnosed as cognitive dysfunction if score \< 24.

Time frame
1 day before surgery; 1 day, 7 days, 3 months and 12 months after surgery
2

Cognitive function

The participants will be evaluated by Montreal Cognitive Assessment scales, diagnosed as cognitive dysfunction if score \< 26

Time frame
1 day before surgery; 1 day, 7 days, 3 months and 12 months after surgery
3

Composition and diversity of gut microbiota

It will be tested by 16s rRNA gene sequencing.

Time frame
1 day before surgery and 7 days after surgery

Secondary outcomes

1

Inflammatory factor

Interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α), C reactive protein (CRP) will be tested by ELISA kit.

Time frame
preoperation, 30 minutes and 24 hours after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jiangjiang Bi

Lead sponsor

Tongji Hospital

Sponsor institution